Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 18, 2021, titled "Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA".
Press Release Nov 18 2021
Filed with NSE · · 2 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Nov 12 2021
- Press Release Nov 10 2021
- Press Release Nov 08 2021
- Press Release Oct 22 2021
- Press Release Oct 08 2021
Later from Zydus Lifesciences
- Press Release Nov 20 2021
- Press Release Nov 23 2021
- Press Release Dec 10 2021
- Press Release Dec 13 2021
- Press Release Dec 16 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences